VolitionRx Limited Capital Expenditures Incurred but Not yet Paid
VolitionRx Limited (VNRX) reported Capital Expenditures Incurred but Not yet Paid of $100.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-03-31
- VolitionRx Limited capital expenditures incurred but not yet paid for fiscal 2025 was $100.00K, a 66.67% decline from fiscal 2024.
- VolitionRx Limited capital expenditures incurred but not yet paid for fiscal 2024 was $300.00K, a 72.73% decline from fiscal 2023.
- VolitionRx Limited capital expenditures incurred but not yet paid for fiscal 2023 was $1.10M, a 31.25% decline from fiscal 2022.
- VolitionRx Limited capital expenditures incurred but not yet paid for fiscal 2022 was $1.60M, a 45.45% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|
| 2025-12-31 | $100.00K 10-K · filed 2026-03-31 |
| 2024-12-31 | $300.00K 10-K · filed 2026-03-31 |
| 2023-12-31 | $1.10M 10-K · filed 2025-03-31 |
| 2022-12-31 | $1.60M 10-K · filed 2024-03-25 |
| 2021-12-31 | $1.10M 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |